期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
证据(循证)医学及在肠粘膜屏障有关研究中的应用
1
作者 王秀荣 于康 +2 位作者 马思陵 何桂珍 蒋朱明 《医学研究通讯》 2002年第12期20-22,共3页
一、证据医学(EBM)的原理 80年代以前的临床研究常以血压、血细胞、血生化、代谢变化等作为有效性指标,而其后的临床研究发现单用这些替代性指标(surrogate parameters)是不够的,需要以患者的预后(包括死亡率、并发症发生率、住院时间... 一、证据医学(EBM)的原理 80年代以前的临床研究常以血压、血细胞、血生化、代谢变化等作为有效性指标,而其后的临床研究发现单用这些替代性指标(surrogate parameters)是不够的,需要以患者的预后(包括死亡率、并发症发生率、住院时间和住院费用等),对患者生活质量的影响及对卫生经济学指标的作用(如功/耗比effect/costratio等)来评价某种治疗方法的效果. 展开更多
关键词 证据(循证)医学 肠粘膜屏障 应用
下载PDF
Evidence-based Clinical Chinese Medicine:What Has Changed Over the Past 20 Years
2
作者 Charlie Changli Xue Anthony Lin Zhang +2 位作者 Brian H May Louise Pobjoy Iris Wenyu Zhou 《广州中医药大学学报》 CAS 2024年第10期2555-2567,共13页
Chinese medicine has been used for centuries to treat a range of health conditions.This history has produced a wealth of classical literature,case studies and clinical research data detailing its use and effectiveness... Chinese medicine has been used for centuries to treat a range of health conditions.This history has produced a wealth of classical literature,case studies and clinical research data detailing its use and effectiveness.However,high-quality and conclusive evidence that meets modern requirements for clinical decision support is lacking.This evidence gap limits the integration of Chinese medicine with contemporary medicine,which in turn limits global access and acceptance of Chinese medicine as a form of safe and effective health care.Over the past 20 years,researchers and organisations around the world,including the World Health Organization(WHO)and United Nations,have worked to support the integration of traditional medicines,such as Chinese medicine,with conventional medicines to improve global health care.This paper provides an overview of Chinese medicine studies published in the top four general medical journals(BMJ,JAMA,Lancet and New England Journal of Medicine)from February 2005 to February 2024 in the past 20 years to highlight the progress in the development of this evidence base.It also highlights key actions taken to promote evidence-based clinical Chinese medicine,including product and practitioner regulation,formalising education standards,and international collaborations.Research conducted at the China-Australia International Research Centre for Chinese Medicine demonstrates the benefits of such a collaboration.Through development of its unique and inclusive‘whole-evidence’approach,plus clinical studies and systematic reviews,the Centre has significantly contributed to the evidence base for clinical Chinese medicine.In addition,its high-impact papers and groundbreaking monographs have been cited in international conventional medicine guidelines.While progress has certainly been made during the past 20 years to build a stronger evidence base for clinical Chinese medicine,there is still a considerable gap that limits its integration with conventional medicine.Future funding and research are needed to continue this work and achieve to safe,effective and accessible traditional medicine as part of the WHO’s Universal Health Coverage strategy. 展开更多
关键词 evidence-based medicine traditional Chinese medicine whole-evidence approach integrated traditional Chinese and western medicine integrative medicine China-Australia International Research Centre for Chinese Medicine
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部